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Why We Do What We Do…
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Recent VIIP/MOS Headlines:
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To date, 24 USOS ISS long-duration spaceflight astronauts have 
developed some or all of the following findings: 
• Hyperopic shift 
• Globe flattening 
• Choroidal folds 
• Cotton wool spots 
• Optic disc edema
• Optic Nerve Sheath Distention
Ocular
ALL are potential signs
of elevated intracranial 
pressure (ICP)
• Mildly elevated post-flight intracranial pressure
- 21 - 29 cm H2O range 
• Upper limit of normal: ~20 cm H2O
• Gray zone: 20.1 – 24.9 cm H2O
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Disc Edema = Modified Frisen Scale Grade >/= 1 at first post-flight eye exam (via fundoscopy)
Globe Flattening = A change compared to preflight (via MRI or ultrasound)
Choroidal Folds = New or worsened compared to pre-flight (via OCT)
Cotton Wool Spot = Presence in-flight or post-flight (via fundoscopy)
Refractive Error = Change in cycloplegic (spherical) refraction ≥0.75D from preflight to first post-flight eye exam
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24 crewmembers 
presented with one or 
more of these findings
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VIIP/MOS Clinical Findings
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 Of the active astronaut population…
• 80% wear vision correction (32% contact lenses)
• Mean age = 47 yrs
• Majority are presbyopic (i.e., a normal, age-related, progressively 
worsening inability to focus clearly on near objects) 
 From postflight questionnaires (1989 - 2011): 25% of short-duration 
(Shuttle) & 50% of long- duration (ISS) mission astronauts report a 
subjective degradation in vision, especially at near
• Provided “Space Anticipation Glasses”
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 Subjective Degradation in Vision (cont):
• Associated w/ Hyperopic Shifts in refractive error due to Globe Flattening
 A 1 mm decrease in axial length will produce a ~3 diopter hyperopic shift
 Largest shift to date is +1.75 diopters
 In presbyopes: Typically decreases near visual 
acuity (VA), but leaves distant VA intact
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 Case Example:
ssociated w/ papilledema
(i.e., disc edema 2o to increased 
intracranial pressure); typically 
bilateral 1 year post-flightPre-flight6 days
MRI
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OD                          Post-flight                           OS
Pre-flight OD                          Post-flight OD
Choroid
Retina
Fovea
 Choroidal thickening 
due to vessel 
engorgement
 Induces choroidal and 
retinal folds
 Can resolve post-flight 
or can persist for 5+ 
yrs
 So far, no clinically-
significant impact on 
BCVA
 Terrestrially: Assoc. w/ 
choroidal tumors, 
scleritis, retrobulbar 
mass, papilledema/IIH
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Example 2Posterior pole fundoscopic images 
OD & OS for two ISS crewmembers
• Top arrows: Choroidal folds
• Bottom arrows: Cotton wool spots
 Cotton wools spots
• Abnormal retinal finding
• Accumulations of axoplasmic
material w/in retinal nerve fiber 
layer
• Caused by ischemia 
reduced axonal transport 
swelling of axon  damaged 
nerve fibers
• Terrestrially: Associated w/ 
diabetes, HTN, central retinal 
vein occlusion
1
Pre-flightost-flight
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Pre-flight fundoscopic 
images of the right 
(OD) & left (OS) optic 
discs 
Post-flight images of 
optic discs, showing 
Grade 3 edema OD & 
Grade 1 edema OS  
OD                                 OS
OD                               OS
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Fundoscopic image of optic disc OD, 
10 days after return to Earth
• Arrows: “C” shaped halo of edema
 Terrestrially: Optic disc edema is 
associated with:
• Unilateral: Optic neuritis, optic 
neuropathy, retinal artery/vein 
occlusion
• Bilateral: Increase in ICP…
 IIH ( “papilledema”)
 Intracranial mass
 Cerebral edema
 Increased CSF production
 Decreased CSF absorption
 Obstructive hydrocephalus
 Venous outflow obstruction 
• Typically reduces VA, enlarges 
blind spot, causes relative 
afferent pupillary defect & color 
impairment  
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Post-flight ultrasound image of 
globe, optic nerve (ON; purple), and 
optic nerve sheath (green). Showing:
• ON Sheath distention
• ON tortuosity 
 ON Sheath terrestrially:
• Normal diameter (ONSD)            
< 5.9 mm
• Enlargement typically 
associated w/ increased ICP
12 mm
Post-Flight OD
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Common Characteristics of the Cases
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 ~6 month duration ISS mission
• [No clinically-significant signs                                                
during short-duration flights]
• Dose response?? 
 All had normal pre-flight eye 
exams
 Past medical history:
• Negative for systemic disease
• None had used medications before/during their mission that 
could increase ICP (e.g., vitamin A, tetracycline, corticosteroids, or 
nalidixic acid)
Common Characteristics of the Cases
Page No. 17
 None complained of headaches, transient vision loss, double 
vision, pulsatile tinnitus, or vision changes during eye mvmts
(i.e., the classic symptoms of idiopathic intracranial hypertension)
 None experienced loss
in best-corrected visual 
acuity, color vision, or 
stereopsis
 Right eye affected more than                                                                
left in all cases
 ISS cabin 
• Normal pressure & oxygen
• Elevated CO2 
 ~0.33-0.5% avg, w/ avg peak ~0.7%
 10x terrestrially: ~0.03-0.04%
Common Characteristics of the Cases
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Next Generation Missions
Mercury n = 6
Gemini *n = 20
Apollo   *n = 33
Skylab   n = 9
Apollo-Soyuz   n = 3
Space Shuttle   *n = 710
Mir   n = 7
International 
Space Station
*n = 55 as of 6/14/16
* Person-flights; may include multiple-time flyers w/in program
We are just entering, relatively speaking, the
long-duration phase of  space exposure… 
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Why is this Happening?
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Microgravity  Cephalad fluid shift  Cerebral venous congestion
Why is this Happening?
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 Current Risk Statement: 
“Visual Impairment Intracranial Pressure” (VIIP)
"Given that the microgravity environment causes cephalad fluid 
shift in astronauts, there is a probability that astronauts will have 
intracranial hypertension (IHT) to some degree, which if left 
untreated, could lead to deleterious health effects.” 
Why is this Happening?
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 Hypothesis #1: Increased intracranial pressure
• The original theory, hence the name “Visual Impairment Intracranial 
Pressure” 
 Hypothesis #2: This is a local ocular eye problem
 Hypothesis #3: Slight IOP reduction + slight ICP increase
 Hypothesis #4: Folate-dependent 1-carbon metabolic pathway 
altered 
 Hypothesis #5: Vessel congestion placing pressure locally 
around optic nerve (“Circle of Zinn-Haller” theory)
• In µGravity, head venous pressure ≈15-20 mmHg
 Standing terrestrially ≈ −20 mmHg 
Why is this Happening?
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In-flight Exacerbating Factors??
Resistive Exercise
High Oral Sodium Intake
Prepackaged Foods…
Up to 5000+ mg/day
In-flight  Pharmaceuticals
High CO2
~10x terrestrial levels
Page No. 24
Medical Surveillance
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Surveillance & Medical Data Collection
 49 ISS expedition missions have been completed (since 2000)
 Sentinel case occurred in 2005
• Optic disc edema and cotton wool spot
 Surveillance/medical data collection is ongoing and has 
evolved
– Began some “VIIP” related testing in 2008 (w/ Exp 18)
– Inconsistent testing until Feb 2010 (Exp 23) when Eye MED B 
came into effect
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Surveillance & Medical Data Collection
Terrestrially
 3T MRI – Special “NASA Astronaut” 
protocol 12-18 months prior to launch
Terrestrially & On-Orbit
 Vision Exam
• Visual Acuity (near & far)
• Amsler grid
 Ocular Ultrasound
 Fundoscopy
 Optical Coherence Tomography (OCT)
 Tonometry (when clinically indicated)
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Surveillance & Medical Data Collection
Visual Acuity & Amsler Grid
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Surveillance & Medical Data Collection
On-orbit Ultrasound Imaging
Elevated optic disc
(Post-flight)
ON sheath distention
ON tortuosity
(Post-flight)
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Surveillance & Medical Data Collection
Fundoscope
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Surveillance & Medical Data Collection
Optical Coherence Tomography (OCT)
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Surveillance & Medical Data Collection
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Surveillance & Medical Data Collection
Optical Coherence Tomography (OCT)
Note: 
Representative 
OCT report;    
Not actual 
astronaut data
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Surveillance & Medical Data Collection
Optical Coherence Tomography (OCT)
Pre-flight OD                          Post-flight OD
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Clinical & Research Update
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Clinical Update: Feb17
Ongoing clinical work
 Correlation between ocular structural changes (OCT) and chronic effect on 
visual function (visual fields testing) 
 Correlation of subcortical white matter hyperintensities (WMH) found on MRI 
and VIIP/MOS signs – 2017
 Refinement of cardiovascular parameters and their correlation with 
VIIP/MOS signs – 2017
 We are evaluating the next generation OCT, “OCT2” to determine if it will 
enhance on orbit imaging/data acquisition
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What We Are Watching Coming From 
Our Research Colleagues
 Ocular Health Study and the Fluid Shifts Study – both finish data 
collection this summer
 Clinical relevance of MRI-based findings
 Implementation of direct ICP measures study pre and post 
mission
 Correlation between HDT with CO2 and VIIP/MOS (EnviHab)
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Questions?
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Back-Up
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The Lamina Cribosa & the Translaminar Pressure 
Gradient: A Mechanism for Papilledema
1G 0G
CSFp
IOP
Area of Interest:
Area of Magnification
Translaminar Pressure Gradients:
